simendan has been researched along with Hibernation, Myocardial in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 16 (59.26) | 29.6817 |
| 2010's | 8 (29.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J; Wu, X; Yan, X; Zhang, Y | 1 |
| Eforakopoulou, M; Georgiadou, M; Katsioula, E; Pavlou, H; Sarafidou, P; Varvarousi, G; Xanthos, T | 1 |
| Axelsson, B; Gupta, A; Häggmark, S; Haney, M; Johansson, G; Svenmarker, S; Tydén, H; Wouters, P | 1 |
| Gams, E; Klocke, RC; Korbmacher, B; Meyer, K; Schipke, JD | 1 |
| Kurt, IH | 1 |
| Choi, YH; Cowan, DB; Del Nido, PJ; Hetzer, R; Stamm, C; Wahlers, TC | 1 |
| Hermansen, SE; How, OJ; Jakobsen, Ø; Müller, S; Myrmel, T; Røsner, A; Stenberg, TA | 1 |
| Busani, S; Cobelli, M; Girardis, M; Pasetto, A; Rinaldi, L; Severino, C | 1 |
| Asopa, S; Elahi, MM; Lam, J; Matata, BM | 1 |
| Cho, S; Hara, T; Maekawa, T; Shibata, I; Sumikawa, K; Ureshino, H; Yoshitomi, O | 1 |
| Delle Karth, G; Heinz, G | 1 |
| Kleber, FX; Lehtonen, LA; Sonntag, S; Sundberg, S | 1 |
| Eriksson, O; Haikala, H; Pollesello, P | 1 |
| Huang, L; Sun, S; Tang, W; Wang, J; Weil, MH | 1 |
| Ayoub, IM; Gazmuri, RJ; Kolarova, JD | 1 |
| Domínguez-Rodríguez, A; Ferrer-Hita, JJ; García-González, MJ | 1 |
| Brussel, T; Ellger, BM; Schmidt, C; Van Aken, HK; Zahn, PK | 1 |
| Domínguez Rodríguez, A; García González, MJ | 1 |
| Carbone, I; Morelli, A; Palantonio, P; Passariello, R; Pietropaoli, P; Rocco, M; Rossi, S; Spadetta, G | 1 |
| Domínguez-Rodríguez, A; García-González, MJ | 1 |
| González-Chon, O; Guevara, M; Márquez, MF; Rivera, J; Romero, KA; Uruchurtu, E | 1 |
| Lechner, E; Mair, R; Moosbauer, W; Pinter, M; Tulzer, G | 1 |
| Cam, N; Kasikcioglu, HA | 1 |
| Behrends, M; Brendt, P; Peters, J | 1 |
| Hettrick, DA; Jamali, IN; Kersten, JR; Pagel, PS; Warltier, DC | 1 |
| Boknik, P; Gams, E; Herzig, JW; Neumann, J; Scholz, H; Zimmermann, N | 1 |
| Ball, NA; Bodi, A; Edes, I; Kristof, E; Papp, Z; Szigeti, G; Walsh, RA | 1 |
6 review(s) available for simendan and Hibernation, Myocardial
| Article | Year |
|---|---|
Role of levosimendan in the management of subarachnoid hemorrhage.
Topics: Cardiotonic Agents; Humans; Hydrazones; Myocardial Stunning; Pyridazines; Simendan; Subarachnoid Hemorrhage | 2016 |
Use of levosimendan in patients with ischemic heart disease following mechanical reperfusion.
Topics: Cardiotonic Agents; Coronary Artery Disease; Humans; Hydrazones; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Pyridazines; Simendan; Vasodilator Agents | 2009 |
Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
Topics: Algorithms; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Myocardial Stunning; Preoperative Care; Pyridazines; Randomized Controlled Trials as Topic; Risk Assessment; Simendan | 2011 |
[Levosimendan in cardiology and intensive care medicine].
Topics: Cardiotonic Agents; Critical Care; Heart Failure; Hemodynamics; Humans; Hydrazones; Myocardial Stunning; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Rate; Vasodilator Agents | 2004 |
Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
Topics: Adenosine Triphosphate; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Models, Biological; Myocardial Stunning; Potassium Channels; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Ventricular Dysfunction | 2006 |
A review of levosimendan in the treatment of heart failure.
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cardiotonic Agents; Coronary Circulation; Drug Therapy, Combination; Heart Failure; Humans; Hydrazones; Matrix Metalloproteinases; Myocardial Contraction; Myocardial Stunning; Neurosecretory Systems; Practice Guidelines as Topic; Pyridazines; Simendan; Treatment Outcome; Ventricular Remodeling | 2006 |
2 trial(s) available for simendan and Hibernation, Myocardial
| Article | Year |
|---|---|
Enhancement of myocardial function and reduction of injury with levosimendan after percutaneous coronary intervention for acute myocardial infarction: a pilot study.
Topics: Biomarkers; Cardiotonic Agents; Emergency Treatment; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardial Stunning; Percutaneous Coronary Intervention; Pilot Projects; Pyridazines; Simendan; Treatment Outcome | 2014 |
The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Volume; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Diastole; Double-Blind Method; Female; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Pyridazines; Simendan; Systole; Treatment Outcome; Vasodilation; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 2004 |
19 other study(ies) available for simendan and Hibernation, Myocardial
| Article | Year |
|---|---|
Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
Topics: Animals; Cardiotonic Agents; Diastole; Disease Models, Animal; Drug Therapy, Combination; Hydrazones; Milrinone; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardial Stunning; Pyridazines; Recovery of Function; Simendan; Sus scrofa; Systole; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2016 |
Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Topics: Animals; Calcium; Cardiotonic Agents; Coronary Circulation; Diastole; Drug Evaluation, Preclinical; Epinephrine; Hemodynamics; Hydrazones; Male; Myocardial Reperfusion Injury; Myocardial Stunning; Oxygen Consumption; Pyridazines; Rabbits; Simendan; Systole; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Calcium sensitisation impairs diastolic relaxation in post-ischaemic myocardium: implications for the use of Ca(2+) sensitising inotropes after cardiac surgery.
Topics: Animals; Ca(2+) Mg(2+)-ATPase; Calcium; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Cytosol; Diacetyl; Diastole; Dopamine; Enzyme Inhibitors; Hydrazones; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardial Stunning; Organ Culture Techniques; Organic Chemicals; Pyridazines; Rabbits; Simendan; Ventricular Function, Left | 2010 |
Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan.
Topics: Analysis of Variance; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Hydrazones; Male; Myocardial Contraction; Myocardial Stunning; Oxygen Consumption; Pyridazines; Simendan; Swine | 2010 |
Levosimendan in cardiac failure after subarachnoid hemorrhage.
Topics: Acute Disease; Adult; Cardiotonic Agents; Critical Care; Embolization, Therapeutic; Female; Heart Failure; Humans; Hydrazones; Italy; Myocardial Stunning; Off-Label Use; Patient Selection; Pyridazines; Radiography; Simendan; Stroke Volume; Subarachnoid Hemorrhage; Treatment Outcome; Ventricular Function, Left | 2010 |
Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Drug Administration Schedule; Female; Hemodynamics; Hydrazones; Male; Milrinone; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardial Stunning; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridazines; Simendan; Swine; Time Factors | 2013 |
Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carbon Isotopes; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart Failure; Heart Rate; Hydrazones; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Myocardial Reperfusion; Myocardial Stunning; Oxygen Consumption; Perfusion; Phosphorus; Pyridazines; Simendan; Ventricular Function, Left | 2004 |
Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
Topics: Analysis of Variance; Animals; Cardiomyopathies; Cardiopulmonary Resuscitation; Cardiotonic Agents; Dobutamine; Heart Arrest; Hydrazones; Male; Myocardial Stunning; Prospective Studies; Pyridazines; Random Allocation; Simendan; Swine | 2005 |
Inotropic options for postresuscitation myocardial dysfunction.
Topics: Animals; Cardiomyopathies; Cardiopulmonary Resuscitation; Cardiotonic Agents; Dobutamine; Heart Arrest; Humans; Hydrazones; Myocardial Stunning; Pyridazines; Simendan; Swine | 2005 |
Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
Topics: Aged; Angioplasty, Balloon, Coronary; Atrial Fibrillation; Calcium Channel Blockers; Cardiotonic Agents; Electrocardiography; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Middle Aged; Myocardial Infarction; Myocardial Stunning; Pericarditis; Pyridazines; Respiration, Artificial; Shock, Cardiogenic; Simendan; Ventricular Dysfunction, Left | 2005 |
Levosimendan: a promising treatment for myocardial stunning?
Topics: Cardiotonic Agents; Facial Neoplasms; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Postoperative Complications; Pyridazines; Simendan | 2006 |
The calcium sensitizer levosimendan improves carbon monoxide poisoning related stunned myocardium: a cardiac magnetic resonance study.
Topics: Adult; Calcium; Carbon Monoxide Poisoning; Cardiotonic Agents; Female; Heart; Humans; Hydrazones; Magnetic Resonance Imaging; Myocardial Stunning; Myocardium; Pyridazines; Radionuclide Imaging; Simendan | 2006 |
[Effect of levosimendan treatment of myocardial stunning and low-output syndrome after cardiac surgery].
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Hydrazones; Myocardial Stunning; Pyridazines; Simendan | 2006 |
Severe stunned myocardium after lightning strike.
Topics: Adult; Cardiotonic Agents; Causality; Critical Care; Disease Progression; Echocardiography; Electrocardiography; Epilepsy, Tonic-Clonic; Exercise Test; Female; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Lightning Injuries; Monitoring, Physiologic; Myocardial Stunning; Pyridazines; Radiopharmaceuticals; Recovery of Function; Severity of Illness Index; Shock, Cardiogenic; Simendan; Technetium Tc 99m Sestamibi; Thallium; Ventricular Dysfunction, Left | 2007 |
Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Topics: Cardiac Output, Low; Cardiotonic Agents; Echocardiography; Follow-Up Studies; Gestational Age; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Pediatric; Male; Myocardial Stunning; Postoperative Complications; Pyridazines; Simendan; Time Factors; Transposition of Great Vessels; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2007 |
Myocardial stunning following no flow ischaemia is diminished by levosimendan or cariporide, without benefits of combined administration.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Guanidines; Guinea Pigs; Hydrazones; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Stunning; Prospective Studies; Pyridazines; Random Allocation; Simendan; Sulfones | 2008 |
Intracoronary levosimendan enhances contractile function of stunned myocardium.
Topics: Animals; Cardiotonic Agents; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Hydrazones; Myocardial Contraction; Myocardial Stunning; Phosphodiesterase Inhibitors; Pyridazines; Simendan | 1997 |
Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Topics: Azocines; Calcium; Cardiotonic Agents; Cyclic AMP; Heart; Humans; Hydrazones; In Vitro Techniques; Myocardial Contraction; Myocardial Stunning; Pyridazines; Simendan | 1998 |
The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts.
Topics: Animals; Cardiotonic Agents; Cyclic AMP; Guinea Pigs; Hydrazones; Male; Myocardial Ischemia; Myocardial Stunning; Myocardium; Phosphorylation; Proteins; Pyridazines; Simendan; Ventricular Function, Left | 1999 |